Commercial Team

Website Photo Size (289 × 375 px)

Andrew Mitchell

Senior Director Business Development

 
Linkedin-in Envelope
Andrew's Profile
Andrea-D

Andrea Dawson

Senior Director, Project Management

Linkedin-in Envelope
Andrea's Profile
Andrea-M

Andrea McCormick

Director, Manufacturing Partnerships, Biologics

Linkedin-in Envelope
Andrea's Profile
Jon_Gingrich

Jon S. Gingrich

Key Account Manager, Biologics

Linkedin-in Envelope
Jon's Profile
Kristina

Kristina Borštnik

Director, Business Development

Linkedin-in Envelope
Kristina's Profile
David-Y

David Young

Manager, Sales

Linkedin-in Envelope
David's Profile
Sauer_Amanda

Amanda Sauer

Project Operations Manager

Envelope
Amanda's Profile
Collins_Sarah

Sarah Collins

Manager, Commercial Operations

Linkedin-in Envelope
Sarah's Profile
Alex-G

Alex Gatien

Project Manager

Linkedin-in Envelope
Alex's Profile
Alex_H

Alex Hendry

Project Manager

Linkedin-in Envelope
Alex's Profile
Maryam

Maryam Khodadadi

Project Manager

Linkedin-in Envelope
Maryam's Profile
Mitch

Mitchell Malboeuf

Project Manager

Linkedin-in Envelope
Mitchell's Profile
Jimmy

Jimmy Rowley

Project Manager

Linkedin-in Envelope
Jimmy's Profile

Andrew Mitchell - Senior Director, Business Development

  • Joined BioVectra in 2017 as the European Business Development Manager
  • Promoted to BioVectra’s Senior Director, Business Development in 2020
  • 30 years of experience in the global pharmaceutical & fine chemical area
  • Experience in synthesis, and fermentation covering both CDMO and Generics industries
  • Worked with a number of organizations, with various specialized capabilities such as large scale chromatography, energetic chemistry, biocatalysis, high containment & microbial fermentation of small molecules

Andrea Dawson - Senior Director, Project Management

  • Bachelor of Chemical Engineering from Dalhousie University.
  • More than 20 years in progressive leadership roles within the Manufacturing environment.
  • Joined BIOVECTRA in March 2010 in the role of Manufacturing Manager (API).
  • Promoted to Director, Contract Manufacturing in 2014.
  • Seconded to a two year term position of Director, Capital Projects in 2018.
  • Appointed to a Project Director position for a 6-month term in 2019.
  • Promoted to BIOVECTRA’s Senior Director, Project Management in 2020.

Andrea McCormick - Director, Manufacturing Partnerships, Biologics

  • B.Sc. in chemistry from University of New Brunswick 1995
  • M.Sc. in Analytical Chemistry from the University of British Columbia 1998
  • Certificate in Project Management from University of California Berkeley 2004
  • Joined BIOVECTRA in 2017 as a Project Manager
  • Prior to joining BIOVECTRA was Manager, Technology Commercialization, Life and Health Sciences at Dalhousie University, Project Manager with Genentech, and an Analytical Chemist at several start-up companies including GeneSoft and AnorMed
  • Joined BIOVECTRA in 2017 as a Project Manager

Jon S. Gingrich – Key Account Manager – Biologics

  • Bachelors of Science – Chemistry – CSUC 1986
  • 12 years experience in the Contract Development and Manufacturing of Biologics industry
  • Subject matter expert in Single Use Bioreactor technology
  • Joined BioVectra’s Business Development group in the summer of 2020

Kristina Borštnik - Director, Business Development

  • B.A. degree in Chemistry and Biology from St. Mary’s College of Maryland
  • Ph.D. degree in Organic Chemistry from Johns Hopkins University
  • 13 years of experience in supporting CMO programs from early phase through commercial manufacture
  • Prior to joining BIOVECTRA, worked at AMRI in a variety of roles including process chemistry, project management, and sales
  • Joined BIOVECTRA in 2020 as Director, Business Development for the East Coast

David Young - Manager, Sales

  • B.Sc. and M.Sc. in Biochemistry from Queen’s University (1986)
  • Worked in R&D, process development, and manufacturing at Cangene Corporation from 1986-1998
  • Promoted to Sales Manager, Contract Manufacturing at Cangene in 1998 – 2009
  • Transitioned to National Sales Manager in Canada for Cangene’s WinRho and HepaGam B products in 2009-2012
  • Established consulting business in the pharma/biotech industry focused on drug development, contract manufacturing, healthcare investment banking and business development in 2012
  • Joined BIOVECTRA as Product Manager for the Bioprocessing Reagents Group in 2016

Amanda Sauer - Project Operations Manager

  • B.Sc. Degree in Chemistry from University of Prince Edward Island (2001)
  • Ph.D. Degree in Chemistry from University of British Columbia (2006)
  • Joined BIOVECTRA in 2006 as a research chemist and in 2007 assumed the role of Project Manager
  • Promoted to Manager, Client Services & Project Management in 2015
  • Promoted to Project Operations Manager in 2020

Sarah Collins - Manager, Commercial Operations

  • Bachelor of Science from Dalhousie in 2006 Major in Neuroscience
  • Masters of Business Administration in 2009 with a concentration in International Business
  • Eight years of experience in project management, business development and commercialization support focusing largely within the bioscience, agriculture, value added agri-food, and energy sectors
  • Joined BioVectra as Project Manager in 2015
  • Promoted to Business Analyst in 2017
  • Promoted to Manager, Commercial Operations in 2020

Alex Gatien – Project Manager

  • 5 years of experience in early stage R&D and pharmaceutical projects.
  • Experience in synthesis, catalysis, and process development in CRO and CDMO environments.
  • Worked with a variety of start-up and multinational pharmaceutical companies to drive product-development processes.
  • Joined BIOVECTRA in 2020 as Project Manager.

Alex Hendry - Project Manager

  • B.Sc. Degree from the University of New Brunswick in 2008, majoring in Medicinal Chemistry with a minor in Marketing
  • Previously worked as a Territory Manager/Account Representative for a beverage distribution company in Atlantic Canada, and has experience in business to business as well as retail sales
  • Joined BioVectra in 2009 as Distribution Sales Representative
  • Promoted to Business Development Representative in 2014
  • Promoted to Project Manager in 2018

Maryam Khodadadi – Project Manager

  • Ph.D. in Food Science and Agricultural Chemistry from McGill University (2012).
  • Continued at McGill for the completion of her Postdoc studies. Her research work was focused on the biosynthesis of products such as prebiotics, and β-Glucans through the valorization of industrial waste streams.
  • Over 12 years of experience in the innovation and biosynthesis of nutraceuticals and bioactive molecules, microalgal fermentation, process scale-up and analytical chemistry.
  • Joined BIOVECTRA’s Project Management team in March 2020.

Mitch Malboeuf – Project Manager

  • C.E.T. in Mechanical Engineering Technology, Ontario, Canada (2011)
  • Has 10 years of experience in the Aerospace, Food & Beverage (Brewery) and Pharmaceutical industries as Manufacturing Engineer Planner and Project Manager
  • Joined BIOVECTRA in 2020 as Project Manager

Jimmy Rowley – Project Manager

  • MSc in Chemistry from UPEI.
  • Has previous experience in sales and has experience running small businesses.
  • Previous worked with companies in developing projects from Pilot scale to commercial scale.
  • Joined BioVectra in 2014 and has held roles in Manufacturing and Process Transfer/Scale-Up as well as assignments with Fermentation and R&D.
  • Has worked on various projects including High Potent, microbial ferments, and a number of Synthetic processes.
  • Promoted to Project Manager in 2019.

SEO plus – Test

  • 20+ years at GSK, leading R&D activities on multiple vaccine programs
  • Recently held positions in industry include: Senior Director (Function Head), Protein Biochemistry; Director, Antigen Design & Prototype Production; and, Associate Director, Antigen Design and Protein Characterization.
  • Key areas of expertise are:
    • Process development of protein Biologics/Recombinant Antigens
    • Recombinant protein expression (mammalian, insect, yeast, bacterial)
    • Production/design of Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles
    • Protein Engineering and Structural Biology
    • Defining quality attributes, biophysical characterization of proteins, and analytical strategy
  • Post graduate degrees in Functional Genomics (Université Laval) and Bioinformatics (MIT); M. Sc. Microbiology and Immunology (Laval).
  • 25+ Patent & 5 Scientific Publications

Normand Blais – Senior Director Development & Innovation, Biologics

  • 20+ years at GSK, leading R&D activities on multiple vaccine programs
  • Recently held positions in industry include: Senior Director (Function Head), Protein Biochemistry; Director, Antigen Design & Prototype Production; and, Associate Director, Antigen Design and Protein Characterization.
  • Key areas of expertise are:
    • Process development of protein Biologics/Recombinant Antigens
    • Recombinant protein expression (mammalian, insect, yeast, bacterial)
    • Production/design of Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles
    • Protein Engineering and Structural Biology
    • Defining quality attributes, biophysical characterization of proteins, and analytical strategy
  • Post graduate degrees in Functional Genomics (Université Laval) and Bioinformatics (MIT); M. Sc. Microbiology and Immunology (Laval).
  • 25+ Patent & 5 Scientific Publications

Oliver Technow - Chief Executive Officer

  • Industry Master Degree from Frankfurt Chamber of Commerce, Frankfurt Germany.
  • More than 20 years of global pharmaceutical industry experience.
  • Held numerous leadership positions in commercial development, marketing and brand management, and lifecycle management and has extensive product launch and market access expertise in Europe and North America.
  • In 1997, joined Eisai GmbH in Frankfurt, Germany and in 2002, was appointed Director, CNS Business Unit; in 2006, was appointed Vice President, Head of Global Marketing for Eisai Inc. in Woodcliff Lake, NJ;  in 2011, was appointed Vice President, Established Products Business Unit; in 2013, was appointed President & General Manager for Eisai Limited in Mississauga, ON.
  • Appointed President of BIOVECTRA Inc., December 10, 2015.
  • Board Director for BIOTECanada
  • Member of the Steering Council of Innovative Medicines Canada (IMC)
  • In 2017, appointed to the Government of Canada’s Health/Bio-sciences Strategic Economic Table
  • In November 2019, promoted to Chief Executive Officer at BIOVECTRA
  • In June 2020, named new Chair of PEI BioAlliance Board of Directors